| Protein Tyrosine Kinase Compound Library A unique collection of 274 compounds for Protein Tyrosine Kinase research. |
Featured Products
- Sinapine
- 5-O-Feruloylquinic acide
- Ganoderic acid DM
- alpha-Spinasterol
- Delta 5-avenasterol
- 3-O-Feruloylquinic acid
- Ginsenoside Rg5
- 5-O-Feruloylquinic acide
- Gomisin N
- Decursin
- 3,6'-Disinapoyl sucrose
- Isochlorogenic acid A
- Schaftoside
- 20R-Ginsenoside Rg2
- A-20R-Ginsenoside Rg2
- Ginsenoside Compound K
- 11-Keto-beta-boswellic acid
- Ganoderol A
- Ganoderol B
- Ganoderiol F
- Cyanidin-3-O-glucoside chloride
- Ginsenoside Rk2
- Ginsenoside Rh3
- Ginsenoside Re
- Salvianolic acid B
- Tenuifolin
- Onjisaponin B
- 1,18-Octadecanediol
- Prosapogenin CP4
- Prosapogenin CP6
Related Products
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- The products in the BioCrick screening libraries are all from plants.
- The biological activities or pharmacological activities of all the BioCrick products are derived from the databases of all over the world the latest literatures, patent reports and clinical validation, you can according to the product manuals on our website to access the relevant literatures, hope that our informations can give some inspirations and help to your research.
- The collections of unique natural products, which include antioxidants, anti-inflammatory, antibacterial, anticancer, and ect. Can be used for high throughput screening (HTS) and high content screening (HCS), is to help you carry out new drug screening, the emergence of new indications and other professional tools.
- Available in stock with overnight delivery and free shipping over $500
- A valuable tool for chemical genomics, epigenetic target identification in pharmacogenomics, and other biological applications.
- Potent, selective and cell-permeable in inhibiting or activating target molecules
- Bioactivity and safety confirmed by preclinical research and clinical trials.
- Detailed files describing potency, selectivity and applications etc.
- Structurally diverse, medicinally active, and cell permeable.
- NMR and HPLC validated to ensure the highest purity.
| Form | Pre-dissolved DMSO solutions | Stability | -20°C: 12 months -80°C: 24 months |
| Packaging | 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37°C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. | ||
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
||
Plate layout: BCL0010
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a | Empty | BMS-754807 | AMG-208 | SGX-523 | GSK1904529A | GW2580 | Vatalanib (PTK787) 2HCl | Ki8751 | Cediranib (AZD217) | PQ 401 | Dovitinib (TKI-258, CHIR-258) | Empty |
| b | Empty | Lenvatinib (E7080) | BMS-536924 | Tivozanib (AV-951) | NVP-AEW541 | PHA-665752 | TCS 359 | Tyrphostin AG 1296 | Brivanib (BMS-540215) | Brivanib Alaninate (BMS-582664) | AG-1024 | Empty |
| c | Empty | SU11274 | OSI-930 | Masitinib (AB1010) | Linifanib (ABT-869) | Foretinib (GSK1363089) | Cabozantinib (XL184, BMS-907351) | BGJ398 | (R)-Crizotinib | Pazopanib (GW-786034) | A-770041 | Empty |
| d | Empty | Afatinib dimaleate | AIM-100 | ALK inhibitor 1 | ALK inhibitor 2 | ALW-II-41-27 | ASP3026 | AST 487 | AVL-292 benzenesulfonate | AXL1717 | BAY 61-3606 | Empty |
| e | Empty | BAY 61-3606 dihydrochloride | BIBX 1382 | BMS-509744 | BMS-599626 Hydrochloride | BMX-IN-1 | Canertinib dihydrochloride | c-FMS inhibitor | c-Met inhibitor 1 | Dasatinib hydrochloride | DCC-2618 | Empty |
| f | Empty | E-3810 | EMD-1214063 | Erlotinib mesylate | Fenretinide | Imatinib hydrochloride | IRAK inhibitor 1 | IRAK inhibitor 2 | IRAK inhibitor 3 | IRAK inhibitor 4 | IRAK inhibitor 6 | Empty |
| g | Empty | IRAK-1-4 Inhibitor I | ITK inhibitor | Ixabepilone | Ki20227 | KX2-391 dihydrochloride | Lck Inhibitor | Lck inhibitor 2 | LDK378 dihydrochloride | LRRK2-IN-1 | LY2801653 | Empty |
| h | Empty | LY2801653 dihydrochloride | LY2874455 | Masitinib mesylate | MK-8033 | Motesanib | N-Desethyl Sunitinib | NVP-BGJ398 phosphate | PF-04217903 methanesulfonate | PND-1186 | PRT062607 Hydrochloride | Empty |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a | Empty | Regorafenib hydrochloride | Regorafenib monohydrate | Silvestrol | SR3335 | SU 5402 | SU14813 | SU14813 double bond Z | SU14813 maleate | SU5416 | TG 100572 | Empty |
| b | Empty | TG 100572 Hydrochloride | TG 100801 | TG 100801 Hydrochloride | Toceranib | Toceranib phosphate | Tyrosine kinase inhibitor | Vandetanib hydrochloride | Vandetanib trifluoroacetate | ZM323881 | Vatalanib | Empty |
| c | Empty | Danusertib (PHA-739358) | KW 2449 | TG101209 | Amuvatinib (MP-470, HPK 56) | Motesanib Diphosphate (AMG-706) | MGCD-265 | JNJ-38877605 | PF-04217903 | TSU-68 (SU6668,Orantinib) | BMS-777607 | Empty |
| d | Empty | KRN 633 | Quizartinib (AC220) | R406 (free base) | Tie2 kinase inhibitor | Staurosporine | PP 1 | PP 2 (AG 1879) | Regorafenib | SKLB610 | Sorafenib Tosylate | Empty |
| e | Empty | TAE684 (NVP-TAE684) | Nintedanib (BIBF 1120) | PD 173074 | GNF-5837 | Crenolanib (CP-868596) | PF-562271 | RAF265 | PF-00562271 | Tivantinib (ARQ 197) | LDK378 | Empty |
| f | Empty | R428 | R788 disodium | Linsitinib | Pazopanib Hydrochloride | AZD4547 | AMG-458 | Axitinib (AG 013736) | CH5424802 | Dovitinib Dilactic acid | GSK1838705A | Empty |
| g | Empty | INCB28060 | MK-2461 | NVP-BVU972 | TAK-285 | R406 | Telatinib (BAY 57-9352) | Vandetanib (ZD6474) | TAE226 (NVP-TAE226) | AZD-3463 | NVP-BHG712 | Empty |
| h | Empty | ZM 306416 | Flumatinib mesylate | PF-431396 | FIIN-2 | BLU9931 | CHMFL-ABL-053 | WZ3146 | G-749 | MK-8033 hydrochloride | Sunitinib | Empty |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a | Empty | 1-NM-PP1 | A 419259 | A 419259 trihydrochloride | SKLB1002 | Cabozantinib malate (XL184) | GZD824 | BMS-794833 | Golvatinib (E7050) | Tyrphostin 9 | PF-573228 | Empty |
| b | Empty | Tandutinib (MLN518) | Mubritinib (TAK 165) | Tyrphostin AG 879 | NVP-ADW742 | Imatinib (STI571) | CP-673451 | KX2-391 | Fostamatinib (R788) | GW441756 | SAR131675 | Empty |
| c | Empty | ZM 323881 HCl | Apatinib | Semaxanib (SU5416) | AV-412 | AV-412 free base | DDR1-IN-1 | GS-9973 | GNE-7915 | Crizotinib hydrochloride | UNC2881 | Empty |
| d | Empty | GNE0877 | CZC-25146 | EG00229 | KX1-004 | Mutated EGFR-IN-1 | GNE-9605 | Defactinib | LDN-214117 | PF-06463922 | LDC1267 | Empty |
| e | Empty | BLZ945 | ACTB-1003 | PF-06447475 | CH5183284 (Debio-1347) | H-9 dihydrochloride | FRATide | pp60 c-src (521-533) (phosphorylated) | N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu | N-Acetyl-O-phosphono-Tyr-Glu Dipentylamide | NTR 368 | Empty |
| f | Empty | L803-mts | ER 27319 maleate | BDNF (human) | HKI 357 | 7,8-Dihydroxyflavone | (E)-FeCP-oxindole | (Z)-FeCP-oxindole | 5'-Fluoroindirubinoxime | DMH4 | CZC 54252 hydrochloride | Empty |
| g | Empty | MLR 1023 | LM 22A4 | GSK2578215A | KB SRC 4 | ANA 12 | Cyclotraxin B | PLX647 | Altiratinib | AZD2932 | SU6656 | Empty |
| h | Empty | CTX0294885 | Pexidartinib (PLX3397) | Entrectinib | BMS-817378 | Fruquintinib(HMPL-013) | EGF816 | CL-387785 (EKI-785) | TP-0903 | Dovitinib (TKI258) Lactate | NPS-1034 | Empty |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a | Empty | GNF-7 | AG 99 | H-7 dihydrochloride | Methyl 2,5-dihydroxycinnamate | Tyrphostin B44, (-) enantiomer | Tyrphostin B44, (+) enantiomer | AG 556 | AG 555 | AG 494 | RR-src | Empty |
| b | Empty | SU 4312 | AG 825 | Herbimycin A | K 252a | Indirubin-3'-oxime | Demethylasterriquinone B1 | GW 583340 dihydrochloride | Ro 08-2750 | BIBU 1361 dihydrochloride | PD 158780 | Empty |
| c | Empty | HDS 029 | PP 3 | JNJ 28871063 hydrochloride | Src I1 | PD 161570 | A 1070722 | KRCA 0008 | HNGF6A | WH-4-023 | ON 146040 | Empty |
| d | Empty | UNC2025 | Lavendustin A | Sorafenib | Damnacanthal | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
| e | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
| f | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
| g | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
| h | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
